Pictet Asset Management Holding SA

Position in IMVT — Immunovant, Inc.

CIK 1993888 CAROUGE, V8

Position in IMVT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$17,814,692

+$6,080,748 QoQ

Shares Held

462,359

-2.1% QoQ

Ownership

0.224%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#36

of 226 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,960,623,527 across 131 Biotechnology names. IMVT ranks #56 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	539,255	$267,864,136
2	RVMD	Revolution Medicines, Inc.	1,014,894	$190,069,348
3	ARGX	Argenx SE	198,282	$183,960,091
4	INSM	INSMED Inc	1,220,353	$130,114,036
5	IONS	Ionis Pharmaceuticals Inc	1,596,998	$126,625,971
6	ROIV	Roivant Sciences Ltd.	3,468,340	$122,744,552
7	BBIO	BridgeBio Pharma, Inc.	1,448,126	$107,856,424
8	RYTM	Rhythm Pharmaceuticals, Inc.	957,785	$106,342,868

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,814,692	462,359	-2.1%	Shares	Sole	2026-07-30
2026-03-31	$11,733,944	472,381	+24.0%	Shares	Sole	2026-04-22
2025-12-31	$9,681,003	380,842	-43.7%	Shares	Sole	2026-01-29
2025-09-30	$10,906,421	676,577	-43.1%	Shares	Sole	2025-11-18
2025-06-30	$19,017,248	1,188,578	0.0%	Shares	Sole	2025-08-13
2025-03-31	$20,312,798	1,188,578	+1.1%	Shares	Sole	2025-05-05
2024-12-31	$29,121,717	1,175,685	-4.4%	Shares	Sole	2025-02-12
2024-09-30	$35,076,109	1,230,309	+4.7%	Shares	Sole	2024-11-12
2024-06-30	$31,015,142	1,174,816	-7.2%	Shares	Sole	2024-08-13
2024-03-31	$40,881,778	1,265,298	-3.2%	Shares	Sole	2024-05-14
2023-12-31	$55,082,068	1,307,431	+15.2%	Shares	Sole	2024-02-13
2023-09-30	$43,580,519	1,135,205	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.